产品详情 |
Edit |   |
Product Name | Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed) |
Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 22-26 kDa, reducing conditions. MW (theoretical): 21.6 kDa. The Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed) from R&D Systems is derived from HEK293. The Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed) has been validated for the following applications: Bioactivity. |
Size | 25 ug |
Concentration | n/a |
Applications | Bioactivity |
Other Names | CD154, CD154 antigen, CD40 antigen ligand, CD40 ligand, CD40L, CD40-L, CD40LG, CD40LIGM, gp39, hCD40L, HIGM1, T-B cell-activating molecule, T-BAM, T-cell antigen Gp39, TNF-related activation protein, TNFSF5, TNFSF5IMD3, TRAP, TRAPtumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome), tumor necrosis factor (ligand) superfamily member 5, Tumor necrosis factor ligand superfamily member 5 |
Gene, Accession, CAS # | CD40LG, Gene ID: 959, Accession: P29965 |
Catalog # | 6420-CL-025 |
Price | |
Order / More Info | Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed) from R&D SYSTEMS, INC. |
Product Specific References | PubMed: 21368231, 22763448, 24498068, 24737107, 28425914, 28455435, 28835384, 29202043, 29358277 |
产品资料 |
|
|